PEDIATRICS Vol. 57 No. 4 April 1976, pp. 529-534
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singsen, B. H.
Right arrow Articles by Hanson, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singsen, B. H.
Right arrow Articles by Hanson, V.

Antinuclear Antibodies and Lupus-like Syndromes in Children Receiving Anticonvulsants

Bernhard H. Singsen M.D.1, Lawrence Fishman M.D.1, and Virgil Hanson M.D.1

1 Department of Pediatrics, University of Southern California School of Medicine, and the Divisions of Rheumatology and Neurology, Childrens Hospital of Los Angeles, Los Angeles, California

Drug-induced systemic lupus erythematosus (SLE)-like syndromes in children are most commonly associated with the administration of ethosuximide, diphenylhydantoin, and trimethadione. Five children receiving ethosuximide who presented with syndromes suggestive of SLE were studied. Each had fever, malar rash, arthritis, and lymphadenopathy. Two children had pleural effusions and another developed myocarditis and pericarditis. Three patients had anti-DNA antibodies associated with low serum C3. In four of five children symptoms disappeared with the discontinuation of ethosuximide; two of these continue to have antinuclear antibodies (ANA). One child continues to have active SLE with nephritis. A group of 101 children from a seizure clinic were tested for the presence of ANA. ANA were found in 14 of 70 children receiving ethosuximide and/or diphenylhydantoin; 2 of 14 had anti-DNA antibodies. Serum ANA titers in the drug-induced SLE group did not differ significantly from those of the asymptomatic seizure patients. ANA were also present in 5 of 23 children receiving phenobarbital only. The induction of ANA by phenobarbital is a possible hypothesis. Quantitative immunoglobulins and C3 were not significantly altered in the asymptomatic children with ANA. Follow-up studies at ten months showed no asymptomatic child with ANA to have developed clinical evidence of SLE. This study suggests that asymptomatic children who develop ANA should have careful observation, but need not have their anticonvulsants discontinued.

Submitted on May 15, 1975
Accepted on August 26, 1975




This article has been cited by other articles:


Home page
 NeurologyHome page
H. P. Attarian, M. J. Berg, M. C. McBride, S. M. Erickson, and G. Erba
Allergies to multiple antiseizure medications: A relationship to ANA and SSA
Neurology, July 1, 1999; 53(2): 434 - 434.
[Full Text]

Home page
 LupusHome page
B. M. Ansell
Drug-Induced Systemic Erythematosus in Childhood
Lupus, June 1, 1993; 2(3): 139 - 140.
[PDF]

Home page
 LupusHome page
B. M. Ansell
Drug-Induced Systemic Lupus Erythematosus in a Nine-Year-Old Boy
Lupus, June 1, 1993; 2(3): 193 - 194.
[Abstract] [PDF]